| Literature DB >> 35566042 |
Zhenming Zang1, Wencong Yang1, Hui Cui2, Runlin Cai3, Chunyuan Li4, Ge Zou1, Bo Wang1, Zhigang She1.
Abstract
Mangrove endophytic fungi represent significant and sustainable sources of novel metabolites with unique structures and excellent biological activities, attracting extensive chemical investigations. In this research, two novel heterodimeric tetrahydroxanthones, aflaxanthones A (1) and B (2), dimerized via an unprecedented 7,7'-linkage, a sp3-sp3 dimeric manner, were isolated from the mangrove endophytic fungus Aspergillus flavus QQYZ. Their structures were elucidated through high resolution electrospray ionization mass spectroscopy (HRESIMS) and nuclear magnetic resonance (NMR) spectroscopy, the absolute configurations of them were determined by a single-crystal X-ray diffraction combined with calculated electronic circular dichroism (ECD) spectra and a 1D potential energy scan. These compounds were evaluated for antifungal activities in vitro and exhibited broad-spectrum and potential antifungal activities against several pathogenic fungi with minimum inhibitory concentration (MIC) values in the range of 3.13-50 μM. They also performed moderate antibacterial activities against several bacteria with MIC values in the range of 12.5-25 μM. This research enriched the resources of lead compounds and templates for marine-derived antimicrobial drugs.Entities:
Keywords: antibacterial activities; antifungal activities; mangrove endophytic fungus; tetrahydroxanthone dimer
Mesh:
Substances:
Year: 2022 PMID: 35566042 PMCID: PMC9103106 DOI: 10.3390/molecules27092691
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Structures of compounds 1 and 2.
1H (500 MHz) and 13C (125 MHz) NMR data of compounds 1 and 2 in MeOD-d4 and CDCl3 , δ in ppm.
| 1 | 2 at 298 K | 2 at 243 K | |||||
|---|---|---|---|---|---|---|---|
| Atom No. | |||||||
| 1 | 162.2, C | 162.3, C | 162.3, C | 162.2, C | |||
| 2 | 107.6, CH | 6.45, s | 107.6, CH | 6.45, s | 107.2, CH | 107.1, CH | 6.45, s |
| 3 | 153.6, C | 153.8, C | 153.7, C | 153.3, C | |||
| 4 | 106.6, CH | 6.42, s | 106.7, CH | 6.42, s | 106.9, CH | 106.9, CH | 6.42, s |
| 4a | 159.3, C | 159.2, C | 159.3, C | 159.2, C | |||
| 10a | 81.5, C | 81.4, C | 81.5, C | 81.4, C | |||
| 5 | 70.8, CH | 4.20, dd (12.4, 4.2) | 70.9, CH | 4.10–4.05, m | 70.9, CH | 4.08–4.04, m | |
| 6 | 29.9, CH2 | 2.10–2.02, m | 33.7, CH2 | 2.56–2.48, m | |||
| 7 | 39.9, CH | 3.44–3.35, m | 38.2, CH | 3.02–2.95, m | |||
| 8 | 175.0, C | 175.4, C | 174.9, C | ||||
| 8a | 105.8, C | 105.8, C | |||||
| 9 | 188.4, C | 188.4, C | 188.3, C | ||||
| 9a | 105.3, C | 105.2, C | 105.8, C | ||||
| 11 | 64.1, CH2 | 4.51, s | 64.1, CH2 | 4.51, s | 64.8, CH2 | 4.53, s | |
| 12 | 26.1, CH3 | 1.48, s | 26.1, CH3 | 1.50, s | 25.5, CH3 | 1.52, s | |
| 1′ | 162.4, C | 162.5, C | 162.1, C | 161.9, C | |||
| 2′ | 110.7, CH | 6.27, s | 110.8, CH | 6.25, s | 110.7, CH | 110.5, CH | 6.25, s |
| 3′ | 150.8, C | 150.6, C | 150.7, C | 150.3, C | |||
| 4′ | 109.8, CH | 6.26, s | 106.7, CH | 6.27, s | 109.9, CH | 109.9, CH | 6.27, s |
| 4a’ | 159.3, C | 159.4, C | 159.0, C | 158.9, C | |||
| 10a’ | 81.8, C | 81.5, C | 81.2, C | 81.0, C | |||
| 5′ | 71.8, CH | 4.12, dd (4.3, 1.9) | 71.9, CH | 4.10–4.05, m | 70.2, CH | 4.13–4.09, m | |
| 6′ | 28.0, CH2 | 2.20–2.14, m | 25.8, CH2 | 2.14–2.07, m | |||
| 7′ | 37.1, CH | 3.44–3.35, m | 35.0, CH | 3.80–3.73, m | |||
| 8′ | 176.9, C | 177.4, C | 176.9, C | ||||
| 8a’ | 107.8, C | 107.8, C | |||||
| 9′ | 188.6, C | 188.4, C | 188.3, C | ||||
| 9a’ | 106.1, C | 106.1, C | 106.4, C | ||||
| 11′ | 22.5, CH3 | 2.25, s | 22.5, CH3 | 2.25, s | 22.6, CH3 | 2.25, s | |
| 12′ | 20.1, CH3 | 1.45, s | 20.1, CH3 | 1.50, s | 27.0, CH3 | 1.45, s | |
The volume ratio of MeOD-d4 and CDCl3 was 1:1.
Figure 2Key 1H-1H COSY, HMBC and NOESY interactions of 1 and 2.
Figure 3X-ray ORTEP drawing of 1 and 2.
Figure 4Experimental ECD spectra in acetonitrile and calculated ECD spectra at B3LYP/6–311+g (d,p) level of 1 and 2.
Figure 5The 1D PES scans on the dihedral angle C8-C7-C7′-C8′ at B3LYP/6–31 g (d,p) level of 1 and 2.
Antifungal and antibacterial activities of 1 and 2.
| MIC of Compounds/μM | ||||
|---|---|---|---|---|
| 1 | 2 | Ketoconazole | Ampicillin | |
|
| 12.5 | 12.5 | 6.25 | NT |
|
| 50 | >100 | 1.56 | NT |
|
| 25 | 12.5 | 1.56 | NT |
|
| 3.13 | >100 | 0.1 | NT |
|
| 12.5 | 25 | 0.1 | NT |
| MRSA | 12.5 | >100 | NT | 0.39 |
|
| >100 | >100 | NT | 0.19 |
|
| 25 | 25 | NT | 0.39 |
Positive control toward fungi. Positive control toward bacteria.